Automation In Biopharma Industry Market Expected to Achieve 7.4% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Automation In Biopharma Industry Market Size By 2025?
In recent times, the market size of automation in the biopharma industry has exhibited a robust growth. The market is projected to rise from $2.08 billion in 2024 to $2.2 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.9%. The surge in growth during the historical phase can be credited to a rise in complexity in biopharmaceutical methods, a demand for greater process efficiency, an expansion in biologics production and development, an insistence on quality management, and the need to truncate time-to-market.

How Big Is the Automation In Biopharma Industry Market Size Expected to Grow by 2029?
In the coming years, the market size for automation in the biopharma industry is projected to see robust growth, scaling up to $2.92 billion in 2029 at a 7.4% CAGR. The growth slated for the forecast period can be traced back to improvements in data integrity and documentation, the upsurge of personalized medicine, establishment of modular and flexible bioprocessing facilities, development of automation platforms, an increased need for biosimilars, adoption of smart sensors and IoT. The forecast period will witness dominant trends like progressions in robotics and automation technologies, advancements in single-use technologies, the incorporation of artificial intelligence in bioprocessing, cutting-edge developments in process analytical technologies (PAT), alliances between biopharma and tech firms, and a heightened focus on sustainability in biopharma automation.

View the full report here:
https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Which Key Market Drivers Powering Automation In Biopharma Industry Market Expansion and Growth?
The growth of automation in the biopharma industry market is anticipated to be propelled by the escalating assimilation of robots in pharmaceutical manufacturing. The term 'robots in pharmaceutical manufacturing' pertains to sophisticated automated systems and machines that carry out a range of tasks involved in producing and packing pharmaceutical products. In numerous pharmaceutical manufacturing applications, robots are widely utilized, for instance, in secondary packaging, intralogistics, laboratory automation, pick and place, automation of pharmacy procedures, and personalized medicine. Their use results in heightened productivity, improved accuracy, minimization of contamination risk, and enhanced safety for employees. For instance, according to the Germany-based International Federation of Robotics, the number of industrial robot installations in the European manufacturing industry reached a record of 92,393 units in September 2024, marking a 9% increase. Of these, 73,534 units or 80% were installed within the European Union, representing a rise of 2% from the preceding year. Hence, the growing use of robots in pharmaceutical manufacturing will boost the advancement of automation in the biopharma industry market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Automation In Biopharma Industry Market?
Technological innovations are emerging as a significant trend in the automation in biopharma industry market. Several leading firms in this sector are concentrating on the development of new product technologies to enhance their market presence. For example, PerkinElmer Inc., a leading company offering scientific solutions from the US, introduced the Cellaca PLX Image Cytometry System in September 2022. This breakthrough automated cell analysis solution is intended to streamline cell and gene therapy research and production. The Cellaca PLX system enables experts to assess essential properties of cell samples, such as their identity, quantity, and quality, using an automated process. This comprehensive system merges image cytometer hardware, software, approved consumables, and traceable data reports, therefore simplifying the calibration and training processes.

What Are the Emerging Segments in the Automation In Biopharma Industry Market?
The automation in biopharma industry market covered in this report is segmented -

1) By Technology: Automation Technology, Digitization Technology
2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase
3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:
1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)
2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12704&type=smp

Who Are the Global Leaders in the Automation In Biopharma Industry Market?
Major companies operating in the automation in biopharma industry market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Which are the Top Profitable Regional Markets for the Automation In Biopharma Industry Industry?
North America was the largest region in the automation in biopharma industry market in 2024. The regions covered in the automation in biopharma industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12704

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.